Fractyl Health, Inc. GUTS
0.49
0.02
4.26%
as of 25 Sep
- Market cap
- $76.4M
- P/E
- 0.0×
Follow GUTS
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(511.03%) | (744.17%) | (778.33%) | 1,063.04% | |
| (99.89%) | (122.85%) | (118.41%) | (146.75%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(189.09%) | (196.71%) | (205.18%) | (295.82%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(1.34) | (1.20) | (0.55) | (0.52) | |
Free Cash Flow |
(86.81) | (90.88) | (87.73) | (82.43) | |
Capital Expenditures |
(0.79) | (0.56) | — | — | |
| Other line items | |||||
Cash ROIC |
(81.74%) | (74.29%) | (76.50%) | (108.57%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.71 | 0.64 | 0.81 | 0.78 | |
Depreciation/Fixed assets |
0.40 | 0.47 | 0.53 | 0.61 | |
Capex/Depreciation |
(0.73) | (0.49) | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.33) | (1.19) | (0.55) | (0.52) | |
Capex per Share |
(0.01) | (0.01) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates